9-cis RA	9-cis retinoic acid
APL	acute promyelocytic leukemia
allo-HSCT	allogeneic hematopoietic stem cell transplantation
AML	acute myeloid leukemia
ANOVA	analysis of variance
APAF1	apoptotic protease-activating factor 1
ATRA	all-trans retinoic acid
auto-HSCT	autologous hematopoietic stem cell transplantation
BAX	Bcl-2-associated X protein
BCL-2	B-cell lymphoma 2
BV	bee venom
CASP3	caspase-3
CASP8	caspase-8
CASP9	caspase-9
cDNA	complementary DNA
Ct	cycle threshold
DIC	disseminated intravascular coagulation
DMSO	dimethyl sulfoxide
ΔΨM	mitochondrial transmembrane potential
FBS	fetal bovine serum
FITC	fluorescein isothiocyanate
HBSS	Hank’s Balanced Salt Solution
HSCT	hematopoietic stem cell transplantation
JC-1	5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazolylcarbocyanine iodide
MCDP	mast cell-degranulating peptide
MMP	mitochondrial membrane potential
MPTP	mitochondrial permeability transition pore
MRD	minimal residual disease
MTT	3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay
PBMCs	peripheral blood mononuclear cells
PBS	phosphate-buffered saline
PI	propidium iodide
PML	promyelocytic leukemia
PML/RARα	promyelocytic leukemia/retinoic acid receptor-alpha fusion protein
qPCR	quantitative polymerase chain reaction (real-time PCR)
RARα	retinoic acid receptor-alpha
RAS	retinoic acid syndrome
RT-PCR	reverse transcription polymerase chain reaction
SD	standard deviation
TxA	anthracycline-based chemotherapy